Axogen

1Exits tracked$200mDisclosed value$200mMedian price0Acquihires

Photo: Tony Webster / Wikimedia Commons, CC BY-SA 4.0

Axogen agrees to buy BioCircuit Technologies and its sutureless Nerve Tape for $200 million

The nerve repair company is funding the all-cash deal with a stock offering, betting that a device that replaces microsutures can widen the pool of surgeons who repair nerves.

Price$200mRaisedn/aLast stageSeedBuyer typeCorporate

Latest in AxogenMore stories here soon.

All Axogen exitsOpen tracker →

10 SepAxogen → BioCircuit TechnologiesAtlanta · Seed · raised n/a$200m$50–250m